SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Evoke plc (EIHDF) , forward earnings yield 22.73%. PEG 0.31 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 4.4
- PEG Ratio 0.31 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
Overall SharesGrow Score: 41/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EIHDF
Valuation Multiples
P/E (TTM)0.0
Forward P/E4.4
PEG Ratio0.31
Forward PEG0.31
P/B Ratio0.00
P/S Ratio0.10
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.43
Forward EPS (Est.)$0.09
Book Value / Share$0.00
Revenue / Share$3.90
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield22.73%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.10 |
$385.98M |
$38.17M |
9.9% |
| 2017 |
$0.03 |
$420.71M |
$9.78M |
2.3% |
| 2018 |
$0.19 |
$405.43M |
$71.1M |
17.5% |
| 2019 |
$0.09 |
$439.2M |
$32.61M |
7.4% |
| 2020 |
$0.02 |
$662.61M |
$8.29M |
1.3% |
| 2021 |
$0.13 |
$712.3M |
$49.9M |
7% |
| 2022 |
$-0.28 |
$1.24B |
$-120.5M |
-9.7% |
| 2023 |
$-0.13 |
$1.71B |
$-56.4M |
-3.3% |
| 2024 |
$-0.43 |
$1.75B |
$-192M |
-10.9% |
